CancerNetwork·4 min read·hard
44 Long-Term Oncological Outcomes After Oncoplastic Therapeutic Mammoplasty With Contralateral Symmetrisation for Early Breast Cancer: A Thirteen-Year Single-Centre Cohort Study
V
Vassilis Pitsinis, Fergus Taylor, Vithya Vera, Rahul Kanitkar, Fiona Hogg
✦AI Summary
A thirteen-year cohort study evaluated the long-term oncological outcomes of therapeutic mammoplasty with contralateral symmetrization for early-stage breast cancer. The findings suggest the procedure is safe, with a 10-year local recurrence rate of 9.7%.
Why it matters
This research provides critical data on the long-term safety and efficacy of oncoplastic breast-conserving surgery, helping clinicians make informed treatment decisions.
Background
healthscience
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 95%
The content is a summary of a peer-reviewed medical study, presenting data objectively.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in